A new stool fixative should be tested in parallel with the laboratory’s current validated fixative using matched specimens and known controls. The study should assess parasite recovery, organism morphology, staining quality, stability, concentration performance, and compatibility with immunoassays or molecular tests. Predetermined acceptance criteria must be met before routine implementation.
Validation should answer three practical questions:
A fixative should not be approved based only on its chemical formulation, manufacturer’s data, or performance with one positive specimen. Collection conditions, stool consistency, fixation time, storage, concentration, staining, and testing platforms can all affect results.
The laboratory director should approve the validation plan, acceptance limits, final conclusions, and implementation decision according to the facility’s quality system and applicable requirements.
The strongest validation compares the candidate fixative directly with the current accepted method. Use matched portions of the same specimen whenever possible. This minimizes differences caused by parasite burden, stool consistency, debris, mucus, and specimen age.
Divide a fresh, well-mixed stool specimen into two portions:
Include several specimen types rather than relying on one sample. A practical study should represent the range encountered in routine testing:
| Comparison material | Purpose |
| Soft or formed stool | Assesses routine fixation and concentration |
| Loose or watery stool | Challenges trophozoite preservation |
| Low-positive specimen | Evaluates recovery near the detection limit |
| Specimen containing cysts | Assesses nuclear and cytoplasmic detail |
| Specimen containing eggs or larvae | Evaluates structure and recovery |
| Coccidia-positive material | Checks special-stain compatibility |
| Microsporidia-positive material | Evaluates preservation of small spores |
| Parasite-negative stool | Assesses background and artifacts |
Positive clinical samples may not always be available. Laboratories may use previously characterized specimens, commercial controls, spiked materials, reference preparations, or another scientifically justified alternative. The material must still challenge the intended performance of the fixative.
Perform enough replicates to distinguish consistent performance from random variation. Include different operators when appropriate, especially if specimen mixing, slide preparation, or microscopy is technique-dependent.
MCC’s guide to creating an end-to-end quality-control program for diagnostic parasitology provides additional context for integrating controls into the complete workflow.
A fixative can preserve morphology but still produce poor recovery during concentration. Compare the number and distribution of organisms recovered from equivalent quantities of stool.
Keep these variables consistent:
Record the organisms detected, approximate quantity, debris level, and ease of examination. Exact counts may not be possible for every specimen, but the comparison should be systematic. Laboratories can use categories such as rare, few, moderate, or many, provided the categories are defined before testing.
Markedly lower recovery in the candidate fixative requires investigation. Possible causes include inadequate mixing, sediment loss, inappropriate rinse steps, flotation characteristics, adhesion to the device, or incompatibility with the laboratory’s concentration procedure.
Review MCC’s concentration-system procedures and its comparison of sedimentation, flotation, and closed-system processing when planning this part of the study.
Morphology should be evaluated on permanent stained smears and direct or concentrated preparations as applicable. Score the structures required for identification—not simply whether staining is present.
A practical four-point scale is:
For protozoan trophozoites and cysts, assess nuclear detail, chromatin pattern, cytoplasmic inclusions, overall shape, shrinkage, and background staining. For helminth eggs and larvae, examine dimensions, shell or cuticle integrity, internal structures, distortion, and collapse.
Slides should be coded or blinded when practical and reviewed by at least two qualified individuals. Separate scoring reduces expectation bias and reveals whether the method produces reproducible interpretations.
The article on standardizing permanent stained smears offers useful guidance for controlling smear thickness, drying, staining, and microscopic review.
Each test method should include controls that demonstrate the expected fixation and detection characteristics. A protozoa control alone does not verify performance for coccidian oocysts, microsporidial spores, or helminth eggs.
Where possible, challenge the fixative with representatives of the organism groups claimed in its intended use:
When suitable organism-positive material is unavailable, laboratories may use surrogate cellular controls to assess basic fixation. However, surrogate material cannot verify every organism-specific feature or downstream assay.
Evaluate the candidate fixative across the storage and transport conditions expected in practice. This may include examination immediately after the minimum fixation period and again after representative storage intervals.
Assess:
If specimens may be transported during hot or cold weather, assess or obtain supporting data for expected temperature excursions. Do not claim stability beyond the conditions demonstrated by the manufacturer and verified by the laboratory.
A universal stool fixative is not automatically compatible with every antigen test, fluorescent assay, culture, or molecular platform. Preservatives may alter epitopes, inhibit enzymatic reactions, damage nucleic acids, or conflict with the test manufacturer’s specimen requirements.
Verify each claimed application separately, including:
Use known positive and negative specimens and compare results with the current validated fixative or another accepted specimen type. Record qualitative agreement, signal intensity, cycle-threshold behavior where relevant, invalid rates, and repeat testing.
Acceptance criteria must be written before results are reviewed. This prevents the laboratory from relaxing expectations after seeing borderline findings.
Example criteria may include:
The exact thresholds should reflect the method, specimen volume, organism prevalence, laboratory risk assessment, and director-approved quality plan.
Maintain a complete validation file containing:
Any failure should be investigated before approval. Corrective action may involve changing the specimen ratio, improving mixing, modifying a validated processing step, retraining staff, testing another lot, or rejecting the fixative.
Medical Chemical Corporation’s Total-Fix® is a single-vial, formalin-, mercury-, and PVA-free stool fixative developed for parasitology workflows. It supports concentration, permanent staining, selected special stains, and compatible fecal assays when used according to validated procedures. Request a sample to begin a side-by-side evaluation, or contact MCC to discuss product documentation and workflow compatibility.
There is no single number suitable for every laboratory. The study must include enough representative positive, negative, low-positive, and varied-consistency specimens to evaluate each intended use. The laboratory director should approve the number based on risk and regulatory requirements.
Yes, when their identity, storage history, and expected results are documented. However, archived samples may not behave like freshly collected stool, so they should be supplemented with fresh or otherwise representative material when possible.
Yes. Successful microscopy or staining does not demonstrate that a fixative is compatible with nucleic acid extraction and amplification. Each molecular platform should be verified according to its instructions and the laboratory’s validation plan.
There is no single feature for every parasite. Protozoan identification may depend on nuclear chromatin and cytoplasmic structures, while helminth identification may depend on egg dimensions, shell characteristics, opercula, plugs, or internal contents.
Reject or place the fixative on hold if it causes clinically meaningful loss of recovery, unacceptable morphology, excessive artifacts, false results, poor stability, or incompatibility with an intended downstream test.
